Clinical Trial Update: Carbon Nanoparticles vs Indocyanine Green [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing carbon nanoparticles to indocyanine green for a lymph node-related outcome; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymph Node Assessment in Cancer

Drugs mentioned

• Carbon Nanoparticles (carbon nanoparticles)
• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: LI XIN-XIANG | Conditions: Number of Lymph Node Retrieved | Phase 2, Phase 3 | Status: UNKNOWN